BioCrea to Present at 12th Annual BIO Investor Forum
(Thomson Reuters ONE) -
BioCrea /
BioCrea to Present at 12th Annual BIO Investor Forum
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
BIO Investor Forum to be held October 8-9 in San Francisco, USA
Radebeul, Germany, October 7, 2013 - BioCrea GmbH (BioCrea), the first-in-class
CNS drug discovery specialists validated through pharma partnerships, announced
that Dr. Tom Kronbach, CEO, will be presenting at the 12th Annual BIO Investor
Forum. Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual
BIO Investor Forum features leading private and emerging public companies. The
meeting will take place October 8-9 at the Palace Hotel in San Francisco, CA,
USA.
"I highly value the opportunities and the comprehensive network with industry
leaders that the BIO Investor Forum offers", said Dr. Tom Kronbach, Chief
Executive Officer of BioCrea GmbH. "As a new member of BIO, I am looking forward
to participate in the conference and to introduce BioCrea as a German CNS drug
development specialist."
Presentation
Dr. Tom Kronbach
October 09, 2013
9:30 am PDT
The Palace Hotel, San Francisco, USA
Room: Pacific Heights
About BioCrea
BioCrea is the Radebeul-based first-in-class drug discovery specialist validated
through pharma partnerships. The company boasts a provable track record in
effective drug discovery driven by knowledge, flexibility and extensive
experience. BioCrea's expertise is founded on the continuing discovery and
optimization of selective ion channel and enzyme modulators - agents that offer
significant potential for maximizing the efficacy and tolerability of new
therapeutics. BioCrea was awarded Top Innovator status of the "Top 100" Most
Innovative Companies in Germany, 2012 by compamedia GmbH.
About the BIO Investor Forum
The 12th Annual BIO Investor Forum is an international investor conference
focused on private and emerging public biotech companies. Because our mission is
to support industry-wide success, we present a broad and unbiased view of
investment opportunities. In addition, the BIO Investor Forum draws business
development executives from leading global pharmaceutical and established
biotechnology companies.
Contact
Dr. Tom Kronbach
CEO, BioCrea GmbH
Tel.: +49 351 / 4043 3332
Fax: +49 351 / 4043 3216
tom.kronbach(at)biocrea.com
Press Release PDF:
http://hugin.info/156612/R/1733869/580621.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioCrea via Thomson Reuters ONE
[HUG#1733869]
Unternehmensinformation / Kurzprofil:
Datum: 07.10.2013 - 09:00 Uhr
Sprache: Deutsch
News-ID 303183
Anzahl Zeichen: 3459
contact information:
Town:
Radebeul
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioCrea to Present at 12th Annual BIO Investor Forum"
steht unter der journalistisch-redaktionellen Verantwortung von
BioCrea (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
